StockData
Cardiol Therapeutics Inc. logo

Cardiol Therapeutics Inc. (CRDL) stock

CRDLNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 40-F on Mar 31, 2026Score 5/30
$0.86−0.02 (-2.28%)

Close on Nov 20, 2026Market cap $86.48MP/E –Yield –

Cardiol Therapeutics operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

For fiscal 2025 it was -C$23.85M. The highest annual figure on record is -C$9.13M in fiscal 2020.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-C$23.85M–
FY2024Dec 31, 2024-C$25.06M–
FY2023Dec 31, 2023-C$25.18M–
FY2022Dec 31, 2022-C$27.22M–
FY2021Dec 31, 2021-C$23.54M–
FY2020Dec 31, 2020-C$9.13M–

More Cardiol Therapeutics figures

See a number that looks wrong?